Anke H.A. van Dijk

Histone Deacetylase Inhibitors Reverse SS18-SSX–Mediated Polycomb Silencing of the Tumor Suppressor <i>Early Growth Response 1</i> in Synovial Sarcoma

Joanna M. Lubieniecka, Diederik R.H. de Bruijn, Le Su et al. · Cancer Research · 2008 · 106 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +15

The Synovial Sarcoma–Associated SS18-SSX2 Fusion Protein Induces Epigenetic Gene (De)Regulation

Diederik R.H. de Bruijn, Susanne V. Allander, Anke H.A. van Dijk et al. · Cancer Research · 2006 · 101 citations

Life Sciences, Genetics, Molecular Biology +14

Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of &lt;i&gt;LRFN5&lt;/i&gt; Expression

Diederik R.H. de Bruijn, Anke H.A. van Dijk, Rolph Pfundt et al. · Molecular Syndromology · 2010 · 75 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences

Esmé Waanders, Blanca Scheijen, Marjolijn C.J. Jongmans et al. · Leukemia · 2016 · 54 citations · Full text

Medicine, Genetics, Oncology +16

The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4

Diederik R.H. de Bruijn, Anke H.A. van Dijk, Marieke Willemse et al. · Oncogene · 2007 · 31 citations

Life Sciences, Cell Biology, Molecular Biology +4